GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (TSX:WEED) » Definitions » Cyclically Adjusted PS Ratio

Canopy Growth (TSX:WEED) Cyclically Adjusted PS Ratio : 1.22 (As of Jun. 10, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Canopy Growth Cyclically Adjusted PS Ratio?

As of today (2024-06-10), Canopy Growth's current share price is C$9.63. Canopy Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was C$7.89. Canopy Growth's Cyclically Adjusted PS Ratio for today is 1.22.

The historical rank and industry rank for Canopy Growth's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSX:WEED' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.53   Med: 12.05   Max: 123.33
Current: 1.22

During the past years, Canopy Growth's highest Cyclically Adjusted PS Ratio was 123.33. The lowest was 0.53. And the median was 12.05.

TSX:WEED's Cyclically Adjusted PS Ratio is ranked better than
67.16% of 743 companies
in the Drug Manufacturers industry
Industry Median: 2.06 vs TSX:WEED: 1.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Canopy Growth's adjusted revenue per share data for the three months ended in Mar. 2024 was C$0.814. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is C$7.89 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Canopy Growth Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Canopy Growth's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Cyclically Adjusted PS Ratio Chart

Canopy Growth Annual Data
Trend Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59.87 81.54 15.42 3.29 1.48

Canopy Growth Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.29 0.68 1.37 0.87 1.48

Competitive Comparison of Canopy Growth's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Canopy Growth's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Canopy Growth's Cyclically Adjusted PS Ratio falls into.



Canopy Growth Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Canopy Growth's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=9.63/7.89
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Canopy Growth's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Canopy Growth's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.814/126.2576*126.2576
=0.814

Current CPI (Mar. 2024) = 126.2576.

Canopy Growth Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201401 0.000 97.261 0.000
201406 0.047 99.473 0.060
201409 0.079 99.394 0.100
201412 0.159 98.367 0.204
201506 0.304 100.500 0.382
201509 0.324 100.421 0.407
201512 0.373 99.947 0.471
201603 0.504 101.054 0.630
201606 0.674 102.002 0.834
201609 0.757 101.765 0.939
201612 0.793 101.449 0.987
201703 0.999 102.634 1.229
201706 0.969 103.029 1.187
201709 1.051 103.345 1.284
201712 1.114 103.345 1.361
201803 1.164 105.004 1.400
201806 1.295 105.557 1.549
201809 1.052 105.636 1.257
201812 2.628 105.399 3.148
201903 2.745 106.979 3.240
201906 2.609 107.690 3.059
201909 2.014 107.611 2.363
201912 3.551 107.769 4.160
202003 3.070 107.927 3.591
202006 3.035 108.401 3.535
202009 3.641 108.164 4.250
202012 4.090 108.559 4.757
202103 3.923 110.298 4.491
202106 3.367 111.720 3.805
202109 3.341 112.905 3.736
202112 3.580 113.774 3.973
202203 1.704 117.646 1.829
202206 2.658 120.806 2.778
202209 1.865 120.648 1.952
202212 1.745 120.964 1.821
202303 1.378 122.702 1.418
202306 1.975 124.203 2.008
202309 0.972 125.230 0.980
202312 0.947 125.072 0.956
202403 0.814 126.258 0.814

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Canopy Growth  (TSX:WEED) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Canopy Growth Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Canopy Growth's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Canopy Growth (TSX:WEED) Business Description

Traded in Other Exchanges
Address
1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Executives
Terry Yanofsky Director
David Angelo Lazzarato Director
Judy A. Schmeling Director

Canopy Growth (TSX:WEED) Headlines